Enzymatic preparation method for 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol

The enzymatic synthesis of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol using site-specific edible lipases addresses the safety concerns of chemical synthesis, achieving high purity and stability for use in health functional foods.

WO2024242502A1PCT designated stage expired Publication Date: 2024-11-28KWANG DONG PHARMA CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
PCT/KR2024/007072
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-25
Filing Date
2024-05-24
Publication Date
2024-11-28

AI Technical Summary

Technical Problem

Chemical synthesis methods for producing 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) are inadequate for ensuring safety as a food product due to the use of unconfirmed catalysts and solvents, limiting the application of this active ingredient in health functional foods.

Method used

An enzymatic synthesis method utilizing site-specific binding ability of edible lipases to produce high-purity PLAG, involving a series of enzyme-catalyzed reactions with glycerol, linoleic acid ethyl ester, palmitic acid ethyl ester, and ethyl acetate, to achieve optimal conditions for intermediate and final product purity.

Benefits of technology

The enzymatic method ensures the stability and safety of PLAG as a food product by replacing unconfirmed catalysts and solvents with edible enzymes, enhancing the purity and yield of the final product, thereby addressing the limitations of chemical synthesis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure PCTKR2024007072-APPB-IMG-000001
    Figure PCTKR2024007072-APPB-IMG-000001
  • Figure PCTKR2024007072-APPB-IMG-000002
    Figure PCTKR2024007072-APPB-IMG-000002
  • Figure PCTKR2024007072-APPB-IMG-000003
    Figure PCTKR2024007072-APPB-IMG-000003
Patent Text Reader

Abstract

The present invention provides an enzymatic preparation method for 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol.
Need to check novelty before this filing date? Find Prior Art

Description

Enzymatic preparation of 1-palmitoyl-2-linoleoyl-3-acetyl-RAC-glycerol

[0001] The present invention relates to an enzymatic method for producing 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG), and more particularly, to an enzymatic method for synthesizing 1-palmitoyl-2-linoleoyl-3-acetyl glycerol (PLAG), which is a trace component contained in 0.002% of deer antler, and is a high-purity deer antler active ingredient utilizing the site-specific binding ability of an edible enzyme (lipase).

[0002] 1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) is an active ingredient of green tea and is known to have the effect of shortening the body's inflammatory response time, and is sold as an immune-modulating health functional food.

[0003] However, 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) is known to be a trace component contained in 0.002% of the deer antler, so extraction / separation from deer antler is limited. Therefore, a method for producing 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) through chemical synthesis was proposed.

[0004] However, in the case of chemical synthesis, it can be seen that the safety as a food product is insufficient because catalysts and solvents whose safety has not been confirmed are used.

[0005] Accordingly, the inventors of the present invention have been paying close attention to a method that can replace the chemical synthesis method and have come up with an enzymatic synthesis method for 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG), a high-purity green tea active ingredient, utilizing the site-specific binding ability of an edible enzyme (lipase), thereby completing the present invention.

[0006] [Prior Art Literature]

[0007] [Patent Document]

[0008] (Patent Document 1) Korean Patent Publication No. 10-2015-0021472

[0009] The purpose of the present invention is to provide a technical problem of an enzymatic synthesis method of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG), a high-purity green tea active ingredient, utilizing the site-specific (sn-1, 3) binding ability of an edible enzyme (lipase).

[0010] Specifically, when the reaction is performed using an enzyme at each step, it can be said that the optimal conditions for each step are combined, and when the conditions are combined, the purity of the intermediates (glyceryl trilinoleate, 1-palmitoyl-2,3-dilinoleoyl-rac-glycerol and 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol) obtained at each step and the final product (1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol) can be increased, so that the present invention can solve the problem.

[0011] In order to solve the above problem, the present invention discloses the following means.

[0012] In one aspect, the present invention provides a method for producing a glyceryl trilinoleate intermediate represented by the following chemical formula 2, comprising: (S1) a step of reacting glycerol and linoleic acid ethyl ester represented by the following chemical formula 1 with a first enzyme to produce a glyceryl trilinoleate intermediate represented by the following chemical formula 2; (S2) a step of reacting the glyceryl trilinoleate intermediate obtained by the step (S1) with palmitic acid ethyl ester using a second enzyme that reacts positionally to produce a 1-palmitoyl-2,3-dilinoleoyl-rac-glycerol intermediate represented by the following chemical formula 3; (S3) A step of producing a 1,3-Dipalmitoyl-2-linoleoyl-rac-glycerol intermediate represented by chemical formula 4 by reacting the 1-palmitoyl-2,3-dilinoleoyl-rac-glycerol intermediate obtained by the step (S2) with palmitic acid ethyl ester using a third enzyme that reacts site-specifically; And (S4) a step of reacting the 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol intermediate obtained by the step (S3) with ethyl acetate with a fourth enzyme that reacts site-specifically to produce 1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol represented by the following chemical formula 5 is provided.

[0013] [Chemical Formula 1]

[0014]

[0015] [Chemical Formula 2]

[0016]

[0017] [Chemical Formula 3]

[0018]

[0019] [Chemical Formula 4]

[0020]

[0021] [Chemical Formula 5]

[0022]

[0023] The manufacturing method according to the present invention has the advantage of ensuring stability as a food, health functional food, or pharmaceutical by using an enzyme having site-specific (sn-1,3) reactivity instead of a catalyst used in a conventional chemical synthesis method.

[0024] The effects of the present invention are not limited to the effects mentioned above, and various effects may be included within a range apparent to those skilled in the art from the contents described below.

[0025] Hereinafter, the present specification will be described in more detail.

[0026] To explain this more specifically, the terms used in this specification are selected from widely used, general terms, taking into account the functions of the present invention. However, these terms may vary depending on the intentions of engineers working in the field, precedents, the emergence of new technologies, etc. Furthermore, in certain cases, terms may be arbitrarily selected by the applicant, and in such cases, their meanings will be described in detail in the description of the relevant invention. Therefore, the terms used in the present invention should not be defined simply as names of terms, but rather based on the meanings of the terms and the overall content of the present invention.

[0027] Unless otherwise defined, all terms used herein, including technical or scientific terms, have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains. Terms defined in commonly used dictionaries should be interpreted as having a meaning consistent with their meaning in the context of the relevant technology, and shall not be interpreted in an idealized or overly formal sense unless explicitly defined herein.

[0028] Numerical ranges are inclusive of the numbers defined in the ranges above. Every maximum numerical limitation given throughout this specification includes every lower numerical limitation, as if that lower numerical limitation were explicitly stated. Every minimum numerical limitation given throughout this specification includes every higher numerical limitation, as if that higher numerical limitation were explicitly stated. Every numerical limitation given throughout this specification will include every better numerical range within that broader numerical range, as if that narrower numerical limitation were explicitly stated.

[0029] The following descriptions and embodiments disclosed in the present invention may also be applied to other descriptions and embodiments. In other words, all combinations of the various elements disclosed in the present invention fall within the scope of the present invention. Furthermore, the scope of the present invention should not be considered limited by the specific descriptions described below.

[0030] Expressions such as “comprising” as used herein should be understood as open-ended terms that imply the possibility of including other embodiments.

[0031] The inventors of the present invention recognized that the conventional chemical synthesis method of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) uses a catalyst and solvent whose safety has not been confirmed, and thus its safety as a food is insufficient, making it difficult to apply health functional foods including 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG), and therefore studied a method that could replace it, and confirmed that 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) can be enzymatically synthesized by utilizing the site-specific binding ability of an edible enzyme (lipase), thereby completing the present invention.

[0032] Hereinafter, the present invention will be described in detail.

[0033] Enzymatic preparation of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol

[0034] In order to solve the above problem, the present invention discloses the following means.

[0035] In one aspect, the present invention comprises the steps of (S1) reacting glycerol and linoleic acid ethyl ester represented by the following chemical formula 1 with a first enzyme to produce a glyceryl trilinoleate intermediate represented by the following chemical formula 2; (S2) reacting the glyceryl trilinoleate intermediate obtained by the step (S1) with palmitic acid ethyl ester using a second enzyme that reacts positionally to produce a 1-palmitoyl-2,3-dilinoleoyl-rac-glycerol intermediate represented by the following chemical formula 3; (S3) A step of producing a 1,3-Dipalmitoyl-2-linoleoyl-rac-glycerol intermediate represented by chemical formula 4 by reacting the 1-palmitoyl-2,3-dilinoleoyl-rac-glycerol intermediate obtained by the step (S2) with palmitic acid ethyl ester using a third enzyme that reacts site-specifically; And (S4) a step of reacting the 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol intermediate obtained by the step (S3) with ethyl acetate with a fourth enzyme that reacts site-specifically to produce 1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol represented by the following chemical formula 5 is provided.

[0036] [Chemical Formula 1]

[0037]

[0038] [Chemical Formula 2]

[0039]

[0040] [Chemical Formula 3]

[0041]

[0042] [Chemical Formula 4]

[0043]

[0044] [Chemical Formula 5]

[0045]

[0046] In the present invention, step (S1) is a step of producing a glyceryl trilinoleate intermediate represented by chemical formula 2 by reacting glycerol and linoleic acid ethyl ester.

[0047] Specifically, glycerol is represented by the chemical formula 1. is the structure of linoleic acid ethyl ester It has the structure of .

[0048] At this time, the OH group of glycerol reacts with the C=O bond of the ester in linoleic acid ethyl ester to obtain the glyceryl trilinoleate intermediate represented by chemical formula 2.

[0049] [Chemical Formula 2]

[0050]

[0051] In the present invention, the first enzyme in step (S1) is Novozyme, an edible enzyme. ® 435 (Novozym ® 435) but is not limited thereto.

[0052] In the present invention, the first enzyme in step (S1) may be added at a ratio of 10 wt% based on the total amount of glycerol and linoleic acid ethyl ester, but is not limited thereto.

[0053] In the present invention, glycerol and linoleic acid ethyl ester in step (S1) may be introduced at a molar ratio of 1:2.5 to 3.5, but is not limited thereto.

[0054] In the present invention, the term “molar ratio” means the molecular ratio composition of each component expressed in gram mole units in the entire mixture of substances.

[0055] In the present invention, in step (S1), glycerol and linoleic acid ethyl ester may be reacted with the first enzyme at a temperature of 50 to 60°C under reduced pressure for 72 hours, but is not limited thereto.

[0056] When the reaction is performed under optimal conditions in step (S1) as described above, there is an advantage in that the quality (purity) of the glyceryl trilinoleate intermediate represented by chemical formula 2 can be increased.

[0057] In the present invention, step (S2) is a reaction in which the sn-1,3 position of glyceryl trilinoleate, which is an intermediate obtained by step (S1) and represented by chemical formula 2, is substituted with palmitoyl through a position-specific reaction, and through the reaction, a 1-Palmitoyl-2,3-Dilinoleoyl-rac-glycerol intermediate, represented by chemical formula 3, is produced.

[0058] In the present invention, the step (S3) is a reaction for substituting palmitoyl at the sn-1,3 position through a position-specific reaction, and is a reaction for producing a 1,3-palmitoyl-2-linoleoyl-rac-glycerol (1,3-Dipalmitoyl-2-Linoleoyl-rac-glycerol) intermediate represented by chemical formula 4 through the reaction.

[0059] Specifically, the step (S2) uses a second enzyme having a position-specific (sn-1,3) reactivity to position-specifically form palmitic acid ethyl ester at positions 1 and 3 of the glyceryl trilinoleate intermediate represented by the chemical formula 2. ) reacts to obtain a triacylglycerol mixture containing 1-Palmitoyl-2,3-Dilinoleoyl-rac-glycerol represented by chemical formula 3. By repeating steps (S2) and (S3), a mixture with an increased yield of the 1,3-Dipalmitoyl-2-linoleoyl-rac-glycerol intermediate represented by chemical formula 4 is obtained.

[0060] [Chemical Formula 3]

[0061]

[0062] [Chemical Formula 4]

[0063]

[0064] In the present invention, the second enzyme and the third enzyme that react position-specifically in the (S2) and (S3) steps are lipozymes. ® RMIM (Lipozyme RMIM) may be used, but is not limited thereto.

[0065] Specifically, the second enzyme and the third enzyme that react site-specifically are enzymes with site-specific (sn-1,3) reactivity.

[0066] In the present invention, the second enzyme in the step (S2) may be added in a ratio of 3 to 7 wt% based on the total amount of the glyceryl trilinoleate intermediate represented by the chemical formula 2 obtained by the step (S1) and palmitic acid ethyl ester, but is not limited thereto.

[0067] In the present invention, the glyceryl trilinoleate intermediate represented by chemical formula 2 obtained by step (S1) in step (S2) and palmitic acid ethyl ester can be introduced at a molar ratio of 1:1.5 to 2.5, but is not limited thereto.

[0068] In the present invention, the glyceryl trilinoleate intermediate and palmitic acid ethyl ester in the step (S2) may be reacted with a second enzyme that reacts site-specifically at a temperature of 35 to 55°C for 60 to 150 minutes, but is not limited thereto.

[0069] In the present invention, the third enzyme in the step (S3) may be added at a ratio of 10 wt% based on the total amount of the triacylglycerol mixture having a high content of the 1-Palmitoyl-2,3-Dilinoleoyl-rac-glycerol intermediate obtained in the step (S2) and palmitic acid ethyl ester, but is not limited thereto.

[0070] In the present invention, the triacylglycerol mixture having a high content of 1-Palmitoyl-2,3-Dilinoleoyl-rac-glycerol represented by the chemical formula 3 in the step (S3) and palmitic acid ethyl ester can be introduced at a molar ratio of 1:6, but is not limited thereto.

[0071] In the present invention, in the step (S3), a triacylglycerol mixture having a high content of 1-Palmitoyl-2,3-Dilinoleoyl-rac-glycerol represented by the chemical formula 3 obtained in the step (S2) and palmitic acid ethyl ester may be reacted with a third enzyme that reacts site-specifically at a temperature of 45°C for 60 minutes, but is not limited thereto.

[0072] In the present invention, when a mixture of 1-Palmitoyl-2,3-Dilinoleoyl-rac-glycerol represented by the chemical formula 3 obtained in the step (S2) is subjected to molecular distillation to obtain triacyl glycerol from which ethyl ester has been removed and the reaction in step (S3) is performed, there is an advantage in that the quality (purity) of the 1,3-Dipalmitoyl-2-linoleoyl-rac-glycerol intermediate represented by the chemical formula 4 can be improved.

[0073] In the present invention, step (S4) is a step of producing 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) represented by chemical formula 5 by substituting an acetyl group at sn-3(1) through a position-specific reaction.

[0074] Specifically, step (S4) uses a fourth enzyme having site-specific (sn-1,3) reactivity to react ethyl acetate at the sn-3(1) position with an acetyl group, thereby obtaining 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) represented by chemical formula 5.

[0075] [Chemical Formula 5]

[0076]

[0077] In the present invention, the fourth enzyme that reacts position-specifically in step (S4) is lipozyme.® RMIM (Lipozyme RMIM) may be used, but is not limited thereto.

[0078] Specifically, the fourth enzyme that reacts site-specifically is an enzyme with site-specific (sn-1,3) reactivity.

[0079] In the present invention, the fourth enzyme in step (S4) may be added at a ratio of 10 wt% based on the total amount of 1,3-Dipalmitoyl-2-linoleoyl-rac-glycerol intermediate represented by chemical formula 4 and ethyl acetate, but is not limited thereto.

[0080] In the present invention, the 1,3-Dipalmitoyl-2-linoleoyl-rac-glycerol intermediate and ethyl acetate in step (S4) can be introduced at a ratio (w / v) of 1:3, but is not limited thereto.

[0081] In the present invention, the reaction may be carried out at a temperature of 50°C for 150 minutes when the 1,3-Dipalmitoyl-2-linoleoyl-rac-glycerol intermediate and ethyl acetate in the step (S4) are reacted with a fourth enzyme that reacts site-specifically, but is not limited thereto.

[0082] When the reaction is performed under optimal conditions in step (S4) as described above, there is an advantage in that the quality (purity) of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) represented by chemical formula 5 can be improved.

[0083] In the present invention, the enzymatic production method of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) may further include a molecular distillation step after the enzymatic synthesis of steps (S2) and (S3), and the molecular distillation step is an essential step that must be included.

[0084] Specifically, after step (S2), step (S3) may be the following steps.

[0085] Step (S3) has the advantage of being able to increase the content of the 1,3-Dipalmitoyl-2-linoleoyl-rac-glycerol intermediate of triacylglycerol compared to step (S2) when reacting the triacylglycerol mixture containing the 1-palmitoyl-2,3-dilinoleoyl-rac-glycerol intermediate obtained in step (S2) with the third enzyme.

[0086] In the present invention, step (S3) has the advantage of improving purity and yield by introducing overreaction of palmitic acid ethyl ester. Specifically, the glyceryl trilinoleate intermediate obtained by step (S1) and the 1-palmitoyl-2,3-dilinoleoyl-rac-glycerol intermediate obtained by step (S2) are intermediates that are removed in the existing reaction, but there is the advantage of improving the yield of the 1,3-Dipalmitoyl-2-linoleoyl-rac-glycerol intermediate through overreaction of palmitic acid ethyl ester.

[0087] In the present invention, the enzymatic production method of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol is an essential step that must include a molecular distillation process in the step of purifying ethyl ester after steps (S1), (S2) and (S3).

[0088] Specifically, the purifying step after step (S4) may be a step of purifying impurities using silica gel column chromatography, but is not limited thereto.

[0089] Hereinafter, the present invention will be described in detail based on examples and comparative examples. However, the following examples and comparative examples are intended only to illustrate the present invention and are not intended to limit the scope of the present invention.

[0090] Example

[0091] Example 1. Preparation of 1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol ('PLAG')

[0092] (1) Step 1: Production of glyceryl trilinoleate (also called 1-linoleoyl-2-linoleoyl-3-linoleoyl glycerol, and also referred to as 'LLLG' in the examples)

[0093] In a 2 L reactor, 15 g of glycerol and 150.13 g of linoleic acid ethyl ester were weighed at a molar ratio of 1:3, and then the mixture was heated in water at 60°C and stirred thoroughly. Novozyme was added at a ratio of 10 wt% of the total substrate amount (sum of glycerol and linoleic acid ethyl ester). ® 435 (Novozym ®435, from Candida antarctica) enzyme was added to the reactor and reacted for 72 hours at 60°C, 0.3 torr, and 750 rpm. After the reaction was completed, the enzyme was filtered through filter paper to obtain the glyceryl trilinoleate (LLLG) reactant (yield: 85%, purity: RP-HPLC 89%, 1 H-NMR 93.2%). The obtained glyceryl trilinoleate (LLLG) contains a small amount of linoleic acid ethyl ester, which is the reaction substrate, and a small amount of monolinolein (MAG) and dilinolein (DAG).

[0094] (2) Step 2 and Step 3: Preparation of 1,3-Dipalmitoyl-2-linoleoyl-rac-glycerol (1,3-Dipalmitoyl-2-Linoleoyl-rac-glycerol; 'PLP')

[0095] Glyceryl trilinoleate (LLLG) and palmitic acid ethyl ester (PEE) obtained by the above first step were weighed at 5 g and 3.2 g, respectively, in a 1:2 molar ratio in a 250 mL reactor, and then added to lipozyme at a ratio of 5 wt% of the total substrate amount (sum of glyceryl trilinoleate (LLLG) and palmitic acid ethyl ester (PEE)). ®RMIM (Lipozyme RMIM, from Rhizomucor miehei) was added to the reactor. The reaction was carried out for 90 minutes while maintaining 45℃. After completion of the reaction, the enzyme was filtered through filter paper to obtain a reactant containing 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP). For purification, molecular distillation was used to obtain triacylglycerol containing 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP) in the reactant (TAG wt% yield: 71.88%, TAG molar yield: 73.90%, PLL content in TAG: 62.23%).

[0096] The TAG mixture containing the obtained 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP) contains not only 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP), but also glyceryl trilinoleate (LLLG) that did not participate in the reaction and reaction by-products dilinoleopalmitin (PLL) and glyceryl tripalmitate (PPP).

[0097] In order to increase the content of 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP) in the composition of this mixture, overreaction of palmitic acid ethyl ester (PEE) was performed. Specifically, the triacylglycerol mixture with a high content of 1-palmitoyl-2,3-dilinoleoyl-rac-glycerol (PLL) obtained in the second step reaction and palmitic acid ethyl ester (PEE) were weighed at 3.00 g and 5.98 g, respectively, at a molar ratio of 1:6 in a 250 mL reactor, and then added to Lipozyme at a ratio of 10 wt% of the total substrate amount (the sum of the triacylglycerol mixture with a high content of 1-palmitoyl-2,3-dilinoleoyl-rac-glycerol (PLL) and palmitic acid ethyl ester (PEE)).® RMIM (Lipozyme RMIM, from Rhizomucor miehei) was added to the reactor. The reaction was carried out for 60 minutes at 45°C. After the reaction was completed, the enzyme was filtered through filter paper to obtain a reactant containing 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP).

[0098] Molecular distillation was used to separate triacylglycerol. In the third step, triacylglycerol containing a higher content of 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP) than the reactant in the second step was obtained (weight % yield: 75.97%, PLP content in TAG: 86.06%).

[0099] Step 4: Preparation of 1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG)

[0100] 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP) and ethyl acetate obtained by the above 3rd step were weighed in a reactor at a ratio (w / v) of 1:3, 3 g and 0.96 g, respectively, and completely dissolved, and then lipozyme was added at a ratio of 10 wt% of the total substrate amount (sum of 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP) and ethyl acetate). ®RMIM (Lipozyme RMIM, from Rhizomucor miehei) was placed in a reactor and the reaction was carried out for 150 minutes at 50℃ and 200 rpm. After the reaction was completed, the enzyme was filtered using filter paper, and ethyl acetate was removed with nitrogen to obtain the 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) reactant (PLAG synthesis rate in the reactant: 47%). The 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) reactant contains not only 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) but also reaction by-products such as 1,3-acetyl-2-linoleoyl-rac-glycerol (ALAG) and unreacted substrates such as triacylglyceride ('TAG').

[0101] Step 5: Purification of 1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol ('PLAG') by silica gel column chromatography

[0102] After packing 5 g of silica gel in a column and adding 20 mL of n-hexane to condition (slurryX), 300 mg of the 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) reactant obtained according to the above step 4 was loaded and filled into an open column. As an eluent, 20 mL each of hexane / ethyl acetate (99.82:0.18), hexane / ethyl acetate (98.8:1.2), hexane / ethyl acetate (97:3), and hexane / ethyl acetate (94:6) were sequentially added without drying. After that, 20 mL of hexane / ethyl acetate (90:10) was added three more times and the eluate was collected. (void volume: 8 mL) A total of 7 eluted fractions were obtained. (Weight % yield: 14.3 %, PLAG purity: 87.4 %) Then, this was developed by thin layer chromatography (TLC) with hexane / diethyl ether / acetic acid (50:50:1) as the developing solvent, and the separation of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) was confirmed. TLC color development was performed using 2,7-dichloro fluororecerin (in EtOH).

[0103] Hereinafter, the present invention will be described in detail based on experimental examples. However, the following experimental examples are intended only to illustrate the present invention and are not intended to limit the scope of the present invention.

[0104] Hereinafter, the present invention will be described in detail based on experimental examples. However, the following experimental examples are intended only to illustrate the present invention and are not intended to limit the scope of the present invention.

[0105] Experimental example

[0106] Experimental Example 1. Exploration of Optimal Conditions for the Production of Glyceryl Trilinoleate ('LLLG') (Stage 1)

[0107] In order to prove that the first step conditions in Example 1 according to the present invention are optimal conditions, various substrate ratios, reaction times, reaction temperatures, and enzyme contents were set as shown in Table 1 below, and glyceryl trilinoleate ('LLLG') composites were manufactured with reference to the first step contents described in Example 1. At this time, when manufacturing the glyceryl trilinoleate ('LLLG') composite, not only the glyceryl trilinoleate ('LLLG') composite but also the reaction by-products monolinolein (MAG) and dilinolein (DAG) were contained, so that the synthesis results of the practically synthesized glyceryl trilinoleate ('LLLG') composites 1 The synthesis rate of TAG was confirmed using H-NMR. The results are shown in Table 2.

[0108] Analysis method

[0109] 600 MHz 1 The area of ​​each peak was determined using H-NMR. Samples were dissolved in chloroform d; 99.8 atom% D at 20 mg / mL and analyzed.

[0110] result

[0111] Referring to Table 2, it was confirmed that the synthesis rate of glyceryl trilinoleate ('LLLG') was the highest when the synthesis was carried out under the first stage conditions according to Example 1.

[0112] Substrate ratio, reaction time (hours), reaction temperature (℃), vacuum conditions, enzyme LLLG, compound 11:36,600.3 torr, Novozyme ®43510 wt% LLLG Composite 21: 312600.3torr Novozyme ® 43510 wt% LLLG Composite 31: 318600.3torr Novozyme ® 43510 wt% LLLG Composite 41: 324600.3 torr Novozyme ® 43510 wt% LLLG composite 51: 330600.3torr Novozyme ® 43510 wt% LLLG Composite 61: 348600.3torr Novozyme ® 43510 wt% LLLG composite in Example 1 1: 372600.3 torr Novozyme ® 43510 wt%

[0113] (In Table 1 above, the substrate ratio refers to the molar ratio of glycerol and linoleic acid ethyl ester. When the molar ratio of glycerol and linoleic acid ethyl ester is 1:3, glycerol and linoleic acid ethyl ester are 15 g and 150.13 g, respectively.)

[0114] Classification results (peak area, %) TAGDAGMAGLLLG composite 162.334.53.2 LLLG composite 276.922.11.0 LLLG composite 382.817.2- LLLG composite 486.613.4- LLLG composite 588.111.9- LLLG composite 692.17.9- LLLG composite in Example 1 93.26.8-

[0115] Experimental Example 2. Exploration of Optimal Conditions for (Step 2) of 1,3-Dipalmitoyl-2-Linoleoyl-rac-glycerol (PLP)

[0116] In order to prove that the second-stage conditions in Example 1 according to the present invention are optimal conditions, various substrate ratios, reaction times, stirring speeds, reaction temperatures, and enzyme contents were set as shown in Table 3 below, and 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP) compounds were manufactured with reference to the second-stage contents described in Example 1 (PLP compounds 1 to 5, PLP compounds in Example 1). At this time, in the production of 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP) compound, not only 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP) compound but also glyceryl trilinoleate (LLLG) that did not participate in the reaction and reaction by-products dilinoleopalmitin (PLL) and glyceryl tripalmitate (PPP) were contained, so the synthesis results of the practically synthesized 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP) compound were evaluated by calculating the peak area of ​​each component using liquid column chromatography, and the results are shown in Table 4.

[0117] Analysis method

[0118] The compositions of 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP), 1-palmitoyl-2,3-dilinoleoyl-glycerol (PLLG), and trilinoleyl (LLLG) were confirmed using reversed-phase high performance liquid chromatography (RP-HPLC, Younglin, Anyang, Korea). The column used for analysis was Nova-pak ®The column used was a C18 column (60 Å, 3.9 mm × 150 mm, 4 μm ID, Waters, Milford, Ireland) and a sedex 75 evaporative light scattering detector (ELSD, Seder, Alfortvil, France) was used as a detector. The pressure of the detector was maintained at 2.2 bar, and nitrogen gas was used. The sample was diluted to a concentration of 0.1–1 mg / mL using Folch solvent (chloroform: methanol = 2:1, v / v) and 20 μL was injected for analysis.

[0119] During the analysis, solvent A (acetonitrile 100%) and solvent B (iso-propanol: hexane = 2:1, v / v) were used as mobile phase solvents and flowed at 1 mL / min. Elution was performed using gradient elution, with the ratio of solvent A and B starting at 80:20 and continuously changing to 54:46 for 45 min and then maintaining it for 15 min. After that, the ratio was continuously changed to 80:20 again for 65 min and maintained at this level for 70 min. 1,3-Dipalmitoyl-2-linoleoyl-rac-glycerol (PLP), 1-palmitoyl-2,3-dilinoleoyl-glycerol (PLLG), and trilinoleyl (LLLG) of each sample were purified according to the partition number (PN), and the peak area% was confirmed.

[0120] result

[0121] Referring to Table 4, it was confirmed that the conditions of Example 1, where the substrate ratio (mol ratio) was 1:2 and the reaction time was 90 minutes, were the conditions under which the least amount of tripalmitin was produced in the second stage reaction.

[0122] Substrate ratioReaction time (min)Stirring speed (rpm)Reaction temperature (℃)EnzymePLP composite 11:23020045Lipozyme ®RMIM5 wt% PLP composite 21: 26020045 Lipozyme ® RMIM5 wt% PLP composite 31: 29020045 Lipozyme ® RMIM5 wt% PLP composite 41: 218020045 Lipozyme ® RMIM5 wt% PLP composite 51: 224020045 Lipozyme ® RMIM5 wt% PLP composite in Example 1 1: 29020045 Lipozyme ® RMIM5 wt%

[0123] (In Table 3 above, the substrate ratio refers to the mol ratio of glyceryl trilinoleate and palmitic acid ethyl ester, and when the mol ratio of glyceryl trilinoleate and palmitic acid ethyl ester is 1:2, glyceryl trilinoleate and palmitic acid ethyl ester are 15 g and 9.70 g, respectively.)

[0124] result

[0125] Referring to Table 3, it was confirmed that the conditions of Example 1 with a reaction time of 90 minutes were the conditions under which the synthesis rate of 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP) was the highest in the second-stage reaction.

[0126] Classification results (peak area, %) LLLGPLLPLPPPPPLP composite 148.5247.603.880 PLP composite 247.8745.846.290 PLP composite 345.4745.249.290 PLP composite 412.0968.3919.520 PLP composite 510.2567.8421.910 PLP composite in Example 1 26.9262.2310.850

[0127] Experimental Example 3. Exploration of Optimal Conditions for (Step 3) of 1,3-Dipalmitoyl-2-Linoleoyl-rac-glycerol (PLP)

[0128] In order to prove that the third step conditions in Example 1 according to the present invention are optimal conditions, various substrate ratios, reaction times, stirring speeds, reaction temperatures, and enzyme contents were set as shown in Table 5 below, and 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP) compounds were manufactured with reference to the second step contents described in Example 1 (PLP compounds 1 to 3, PLP compounds in Example 1). At this time, in the production of 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP) compound, not only 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP) compound but also glyceryl trilinoleate (LLLG) that did not participate in the reaction and reaction by-products dilinoleopalmitin (PLL) and glyceryl tripalmitate (PPP) were contained, so the synthesis results of the practically synthesized 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP) compound were evaluated by calculating the peak area of ​​each component using liquid column chromatography, and the results are shown in Table 6.

[0129] Analysis method

[0130] The compositions of 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP), 1-palmitoyl-2,3-dilinoleoyl-glycerol (PLLG), and trilinoleyl (LLLG) were confirmed using reversed-phase high performance liquid chromatography (RP-HPLC, Younglin, Anyang, Korea). The column used for analysis was Nova-pak ®The column used was a C18 column (60 Å, 3.9 mm × 150 mm, 4 μm ID, Waters, Milford, Ireland) and a sedex 75 evaporative light scattering detector (ELSD, Seder, Alfortvil, France) was used as a detector. The pressure of the detector was maintained at 2.2 bar, and nitrogen gas was used. The sample was diluted to a concentration of 0.1–1 mg / mL using Folch solvent (chloroform: methanol = 2:1, v / v) and 20 μL was injected for analysis.

[0131] During the analysis, solvent A (acetonitrile 100%) and solvent B (iso-propanol: hexane = 2:1, v / v) were used as mobile phase solvents and flowed at 1 mL / min. Elution was performed using gradient elution, with the ratio of solvent A and B starting at 80:20 and continuously changing to 54:46 for 45 min and then maintaining it for 15 min. After that, the ratio was continuously changed to 80:20 again for 65 min and maintained at this level for 70 min. 1,3-Dipalmitoyl-2-linoleoyl-rac-glycerol (PLP), 1-palmitoyl-2,3-dilinoleoyl-glycerol (PLLG), and trilinoleyl (LLLG) of each sample were purified according to the partition number (PN), and the peak area% was confirmed.

[0132] result

[0133] Referring to Table 5, it was confirmed that the synthesis rate of 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol (PLP) was the highest under the conditions of Example 1 with a reaction time of 60 minutes.

[0134] Substrate ratioReaction time (min)Stirring speed (rpm)Reaction temperature (℃)EnzymePLP composite 11:63020045Lipozyme ® RMIM10 wt% PLP composite 21: 66020045 Lipozyme® RMIM10 wt% PLP composite 31: 69020045 Lipozyme ® RMIM10 wt% PLP composite in Example 1 1: 66020045 Lipozyme ® RMIM10 wt%

[0135] (In Table 5 above, the substrate ratio refers to the mol ratio of triacylglycerol with a high content of 1-palmitoyl-2,3-dilinoleoyl-glycerol (PLLG) and palmitic acid ethyl ester, and when the mol ratio of triacylglycerol with a high content of 1-palmitoyl-2,3-dilinoleoyl-glycerol and palmitic acid ethyl ester is 1:6, triacylglycerol with a high content of 1-palmitoyl-2,3-dilinoleoyl-glycerol (PLLG) and palmitic acid ethyl ester are 3 g and 5.98 g, respectively.)

[0136] Classification results (peak area, %) LLLGPLLPLPPPPPLP composite 10.23 18.84 79.85 1.08 PLP composite 2-18.56 80.29 1.15 PLP composite 3-14.64 84.2 11.15 PLP composite in Example 1 0.10 12.67 86.06 1.17

[0137] Experimental Example 4. Exploration of Optimal Conditions for (Step 4) of 1-Palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol (PLAG)

[0138] In order to prove that the fourth step conditions in Example 1 according to the present invention are optimal conditions, various substrate ratios, reaction times, stirring speeds, reaction temperatures, and types and contents of enzymes were set as shown in Table 7 below to manufacture 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol (PLAG) compounds (PLAG compounds 1 to 4, PLAG compounds in Example 1). At this time, when manufacturing the 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol (PLAG) compound, not only the 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol (PLAG) compound but also the reaction by-product 1,3-acetyl-2-linoleoyl-Rac-glycerol, the unreacted substrate triacylglyceride (TAG), and other reaction by-products were contained, so the synthesis results of the practically synthesized 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol (PLAG) compound were evaluated by calculating the peak area of ​​each component using liquid column chromatography, and the results are shown in Table 8.

[0139] Analysis method

[0140] For the analysis of 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol (PLAG), solvent A (methanol 100%) and solvent B (iso-propanol: hexane = 5:4, v / v) were used as mobile phase solvents, flowing at 1 mL / min. Elution was performed using a gradient elution in which the ratio of solvents A and B was started at 100:0 and continuously changed to 50:50 for 10 min, and then maintained at this ratio for 6 min. After that, the analysis was completed by continuously changing the ratio of A and B to 100:0 for 5 min. The peak area of ​​1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol (PLAG) was confirmed through the retention time (RT).

[0141] result

[0142] Referring to Table 8, it was confirmed that the synthesis rate of 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol (PLAG) was the highest under the conditions of Example 1.

[0143] Substrate ratioReaction time (min)Reaction temperature (℃)EnzymePLAG compound 11:33045Lipozyme ® RMIM10 wt% PLAG compound 21: 39045 lipozyme ® RMIM10 wt% PLAG composite in Example 1 1: 315045 Lipozyme ® RMIM10 wt% PLAG compound 31:321045 lipozyme ® RMIM10 wt% PLAG compound 41: 3108045 lipozyme ® RMIM10 wt%

[0144] (In Table 7 above, the substrate ratio refers to the ratio (w / w) of 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol and ethyl acetate, and when the ratio (w / w) of 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol and ethyl acetate is 1:3, 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol and ethyl acetate are 3 g and 0.95 g, respectively.)

[0145] Classification results (peak area, %)PLAGTAGOthersPLAG composite 133.7562.124.13PLAG composite 233.0759.817.12PLAG composite in Example 143.8839.0417.08PLAG composite 334.3241.8923.79PLAG composite 444.9628.3826.66

[0146] While specific aspects of the present invention have been described in detail above, it should be apparent to those skilled in the relevant technical field that these specific descriptions are merely preferred embodiments and do not limit the scope of the present invention. Therefore, the actual scope of the present invention will be defined by the appended claims and their equivalents.

Claims

1. (S1) A step of producing a glyceryl trilinoleate intermediate represented by the following chemical formula 2 by reacting glycerol and linoleic acid ethyl ester represented by the following chemical formula 1 with a first enzyme; (S2) A step of producing a 1-palmitoyl-2,3-dilinoleoyl-rac-glycerol intermediate represented by the following chemical formula 3 by reacting the glyceryl trilinoleate intermediate obtained by the step (S1) with palmitic acid ethyl ester using a second enzyme that reacts site-specifically; (S3) a step of producing a 1,3-Dipalmitoyl-2-linoleoyl-rac-glycerol intermediate represented by chemical formula 4 by reacting the 1-palmitoyl-2,3-dilinoleoyl-rac-glycerol intermediate obtained by the step (S2) with palmitic acid ethyl ester using a third enzyme that reacts site-specifically; and (S4) A step of producing 1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol represented by the following chemical formula 5 by reacting the 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol intermediate obtained by the above step (S3) with ethyl acetate with a fourth enzyme that reacts site-specifically. A method for enzymatically producing 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol comprising: [Chemical Formula 1] [Chemical Formula 2] [Chemical Formula 3] [Chemical Formula 4] [Chemical Formula 5] 2. In the first paragraph, the first enzyme in step (S1) is Novozyme, an edible enzyme. ® 435 (Novozym ® A method for the enzymatic production of 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol characterized by being 435).

3. A method for enzymatically producing 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol, characterized in that in step (S1), the first enzyme is added at a ratio of 10 wt% based on the total amount of glycerol and linoleic acid ethyl ester.

4. An enzymatic method for producing 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol, characterized in that in step (S1), glycerol and linoleic acid ethyl ester are introduced at a molar ratio of 1:2.5 to 3.

5.

5. An enzymatic method for producing 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol, characterized in that in step (S1), glycerol and linoleic acid ethyl ester are reacted with the first enzyme at a temperature of 50 to 60°C for 72 hours.

6. In the first paragraph, the second enzyme and the third enzyme that react position-specifically in the steps (S2) and (S3) are lipozymes. ® A method for enzymatically producing 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol, characterized in that it is RMIM (Lipozyme RMIM).

7. A method for enzymatically producing 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol, characterized in that in the step (S2), the second enzyme is added in a ratio of 3 to 7 wt% based on the total amount of the glyceryl trilinoleate intermediate and palmitic acid ethyl ester.

8. An enzymatic method for producing 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol, characterized in that in the step (S2), the glyceryl trilinoleate intermediate and palmitic acid ethyl ester are introduced at a molar ratio of 1:1.5 to 2.

5.

9. An enzymatic method for producing 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol, characterized in that the glyceryl trilinoleate intermediate and palmitic acid ethyl ester in step (S2) are reacted with a second enzyme that reacts site-specifically at a temperature of 35 to 50°C for 60 to 150 minutes.

10. A method for enzymatically producing 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol, characterized in that in the step (S3), the third enzyme is added at a ratio of 10 wt% based on the total amount of the 1-palmitoyl-2,3-dilinoleoyl-rac-glycerol intermediate and palmitic acid ethyl ester.

11. A method for enzymatically producing 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol, characterized in that in the step (S3), the 1-palmitoyl-2,3-dilinoleoyl-rac-glycerol intermediate and palmitic acid ethyl ester are introduced at a molar ratio of 1:

6.

12. An enzymatic method for producing 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol, characterized in that the 1-palmitoyl-2,3-dilinoleoyl-rac-glycerol intermediate and palmitic acid ethyl ester in the step (S3) are reacted with a third enzyme that reacts site-specifically at a temperature of 35 to 50°C for 60 to 150 minutes.

13. In the first paragraph, the fourth enzyme that reacts position-specifically in the step (S4) is lipozyme. ® A method for enzymatically producing 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol, characterized in that it is RMIM (Lipozyme RMIM).

14. A method for enzymatically producing 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol, characterized in that in the first paragraph, the fourth enzyme in the step (S4) is added at a ratio of 10 wt% based on the total amount of the 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol intermediate and ethyl acetate.

15. An enzymatic method for producing 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol, characterized in that in the step (S4), the 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol intermediate and ethyl acetate are introduced at a ratio (w / v) of 1:

3.

16. An enzymatic method for producing 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol, characterized in that the 1,3-dipalmitoyl-2-linoleoyl-rac-glycerol intermediate in step (S4) and the fourth enzyme that reacts positionally with ethyl acetate are reacted at a temperature of 35 to 50°C for 60 to 150 minutes.

17. An enzymatic method for producing 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol, characterized in that, after steps (S2) and (S3), the intermediate triacylglycerol is separated through molecular distillation.

18. An enzymatic method for producing 1-palmitoyl-2-linoleoyl-3-acetyl-Rac-glycerol, characterized in that it further comprises a purifying step after the step (S4) in the first paragraph.

Citation Information

Patent Citations

  • Process for the regioselective preparation of glycerolderivatives and their intermediates

    KR1020070010841A

  • Communication module for electric vehicle charging system based on open charge point protocol and operation method of that

    KR102363539B1

  • A smart aquaponics dome system

    KR102698011B1

  • Method for preparing monoacetyglycerols and esters thereof

    US20150266803A1

  • KR20190123123A